Loading...
dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 1230118007

Production
add
1230118007
The component that hold information about this concept.
Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)

SCTID: 1230118007, Defined, Active


1230118007|Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)|
  • en Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
  • en Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)

1230118007 |Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)|

=== 385112003 |Conventional release cutaneous powder (dose form)| +
    1230117002 |Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)| :
        { 732943007 |Has basis of strength substance (attribute)| = 108867000 |Sulfacetamide sodium (substance)|,
          733722007 |Has concentration strength denominator unit (attribute)| = 258682000 |Gram (qualifier value)|,
          733725009 |Has concentration strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)|,
          762949000 |Has precise active ingredient (attribute)| = 108867000 |Sulfacetamide sodium (substance)| }
        { 732943007 |Has basis of strength substance (attribute)| = 5220000 |Bacitracin (substance)|,
          733722007 |Has concentration strength denominator unit (attribute)| = 258682000 |Gram (qualifier value)|,
          733725009 |Has concentration strength numerator unit (attribute)| = 767525000 |Unit (qualifier value)|,
          762949000 |Has precise active ingredient (attribute)| = 5220000 |Bacitracin (substance)| }
        { 732943007 |Has basis of strength substance (attribute)| = 70961008 |Neomycin sulfate (substance)|,
          733722007 |Has concentration strength denominator unit (attribute)| = 258682000 |Gram (qualifier value)|,
          733725009 |Has concentration strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)|,
          762949000 |Has precise active ingredient (attribute)| = 70961008 |Neomycin sulfate (substance)| }
Active

5067244011 - Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder (en) View

5067244011
en
Synonym (core metadata concept)
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

5067245012 - Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug) (en) View

5067245012
en
Fully specified name (core metadata concept)
Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

Relationship (15223846020) - 1230118007 -> 787994008 (766939001) View

766939001 |Plays role (attribute)|
787994008 |Antibacterial therapeutic role (role)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
False

Relationship (15223843028) - 1230118007 -> 1230117002 (116680003) View

116680003 |Is a (attribute)|
1230117002 |Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223844023) - 1230118007 -> 385112003 (411116001) View

411116001 |Has dose form (attribute)|
385112003 |Conventional release cutaneous powder (dose form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223847027) - 1230118007 -> 108867000 (762949000) View

762949000 |Has precise active ingredient (attribute)|
108867000 |Sulfacetamide sodium (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223848021) - 1230118007 -> 108867000 (732943007) View

732943007 |Has basis of strength substance (attribute)|
108867000 |Sulfacetamide sodium (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223850029) - 1230118007 -> 258684004 (733725009) View

733725009 |Has concentration strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223852021) - 1230118007 -> 258682000 (733722007) View

733722007 |Has concentration strength denominator unit (attribute)|
258682000 |Gram (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223853027) - 1230118007 -> 5220000 (762949000) View

762949000 |Has precise active ingredient (attribute)|
5220000 |Bacitracin (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223854022) - 1230118007 -> 5220000 (732943007) View

732943007 |Has basis of strength substance (attribute)|
5220000 |Bacitracin (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223856024) - 1230118007 -> 767525000 (733725009) View

733725009 |Has concentration strength numerator unit (attribute)|
767525000 |Unit (qualifier value)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223858020) - 1230118007 -> 258682000 (733722007) View

733722007 |Has concentration strength denominator unit (attribute)|
258682000 |Gram (qualifier value)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223859028) - 1230118007 -> 70961008 (762949000) View

762949000 |Has precise active ingredient (attribute)|
70961008 |Neomycin sulfate (substance)|
3
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223860022) - 1230118007 -> 70961008 (732943007) View

732943007 |Has basis of strength substance (attribute)|
70961008 |Neomycin sulfate (substance)|
3
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223862025) - 1230118007 -> 258684004 (733725009) View

733725009 |Has concentration strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
3
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15223864029) - 1230118007 -> 258682000 (733722007) View

733722007 |Has concentration strength denominator unit (attribute)|
258682000 |Gram (qualifier value)|
3
900000000000011006 |Inferred relationship (core metadata concept)|
True

1230117002 View

1230117002
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)
Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

385112003 View

385112003
Conventional release cutaneous powder (dose form)
Topical powder
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True
esc